Routes of drug administration
Route  | Abbreviation  | Description  | 
Intracerebroventricular  | i.c.v.  | Into the ventricles of the brain  | 
Intra-arterial  | i.a.  | Into the lumen of an artery  | 
Intracerebral  | i.c.  | Into the brain  | 
Intradermal  | i.d.  | Into the dermal layer of the skin  | 
Intramuscular  | i.m.  | Into a skeletal muscle  | 
Intragastric  | i.g.  | Into the stomach  | 
Intraperitoneal  | i.p.  | Into the peritoneum (body cavity)  | 
Intravenous  | i.v.  | Into a vein  | 
Oral  | p.o.  | By mouth  | 
Subcutaneous  | s.c.  | Under the skin  | 
quaque die (Latin)  | q.d.  | once a day  | 
bis in die (Latin)  | b.i.d.  | twice a day  | 
ter in die (Latin)  | t.i.d.  | three times a day  | 
Targets
Abbreviation  | Description  | 
Abl  | V-abl Abelson murine leukemia viral oncogene homolog 1  | 
ALK  | anaplastic lymphoma kinase  | 
ATM  | Ataxia telangiectasia mutated  | 
B-Raf  | B-Raf proto-oncogene serine/threonine-protein kinase (B-RAF), also known as V-raf murine sarcoma viral oncogene homolog B1  | 
Bcl-2  | B-cell lymphoma 2  | 
Bcr  | breakpoint cluster region  | 
Caspases  | cysteine-aspartic proteases or cysteine-dependent aspartate-directed proteases  | 
CCR5  | co-receptors chemokine receptor 5  | 
CDK  | Cyclin-dependent kinase  | 
CFTR potentiator  | Cystic fibrosis transmembrane conductance regulator  | 
CTSK  | Cathepsin K  | 
c-Kit  | CD117 (cluster of differentiation 117), also called KIT or C-kit receptor  | 
c-Met  | mesenchymal-epithelial transition  | 
DNA-PK  | DNA-dependent protein kinase  | 
DPP-4  | Dipeptidyl peptidase-4  | 
EGFR  | Epidermal growth factor receptor  | 
Factor Xa  | Stuart-Prower factor, an enzyme of the coagulation cascade  | 
FGFR  | Fibroblast growth factor receptor  | 
FLT-3  | fms-like tyrosine kinase-3  | 
FTS  | Farnesyl thiosalicylic acid  | 
GSK-3  | Glycogen synthase kinase 3  | 
HER2  | Human epidermal growth factor receptor 2  | 
HDAC  | Histone deacetylase  | 
HIF  | Hypoxia-inducible factor  | 
HSP-70  | heat-shock protein-70  | 
HSP-90  | heat-shock protein-90  | 
IGF-1R  | Insulin-like growth factor 1 receptor  | 
JAK  | Janus kinase  | 
JNK  | c-Jun N-terminal kinases  | 
Ksp  | Kinesin spindle protein  | 
MAPK  | Mitogen-activated Protein Kinase  | 
MEK  | MAPK/ERK kinase  | 
mGluRs  | metabotropic glutamate receptors  | 
mTOR  | Mammalian target of rapamycin  | 
NF-kB  | Nuclear factor-κB  | 
p38 MAPK  | p38 Mitogen-activated Protein Kinase  | 
p53  | protein 53 or tumor protein 53  | 
PARP  | Poly (ADP-ribose) polymerase  | 
PDGFR  | platelet-derived growth factor receptor  | 
PDK-1  | phosphoinositide-dependent kinase-1  | 
Rho  | ρ factor  | 
PI3K  | Phosphatidylinositol 3-kinases  | 
PKC  | protein kinase C  | 
PLK  | Polo-like kinase  | 
Ras  | renin-angiotensin system  | 
RNAP  | RNA Polymerase or RNApol  | 
S1PR1  | Sphingosine-1-phosphate receptor (S1P1) also known as endothelial differentiation gene 1 (EDG1)  | 
sPLA2  | Secreted phospholipase A2  | 
Src  | Rous sarcoma oncogene cellular homolog  | 
Stat  | Signal Transducers and Activator of Transcription  | 
Survivin  | baculoviral inhibitor of apoptosis repeat-containing 5 or BIRC5  | 
TGF  | Transforming growth factor  | 
TNF  | Tumor necrosis factor  | 
VEGFR  | Vascular Endothelial Growth Factor Receptor  | 
Wnt  | a portmanteau of int and Wg and stands for "Wingless-related integration site"  |